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The aim of coronary artery bypass grafting (CABG) is to prolong life
and reduce symptoms. However, when compared with percutan-
eous coronary intervention, CABG is a signiﬁcantly more invasive
operation, associated with a higher rate of early stroke. Off-pump
CAB (OPCAB) brought the hope, about 25 years ago, that various
CABG-related morbidities, and even perhaps mortality, would
evaporate if cardiopulmonary bypass was to be eliminated. Yet,
numerous risk-adjusted studies and large meta-analysis of propen-
sity score-adjusted studies showed that this hoped superiority of
OPCAB regarding mortality and several short-term outcomes did
not materialize in large randomized trials [1, 2].
In this issue of the European Journal of Cardiothoracic Surgery,
Deppe et al. [3] report the results of one of the largest meta-
analyses of randomized controlled trials (RCTs) comparing OPCAB
and on-pump CABG (ONCAB). In summary, the analysis was
performed on 16 904 patients from 51 studies. There was no
difference between the groups in the incidence of mortality, myo-
cardial infarction (MI) or major adverse cardiac and cerebro-vas-
cular events (MACCEs) at 30 days or at longest available follow-up.
The incidence of mid-term graft failure [odds ratio (OR): 1.37; 95%
conﬁdence interval (CI): 1.09–1.72] and the need for repeat
revascularization (OR: 1.55; 95% CI: 1.33–1.80) was increased after
off-pump while on-pump surgery was associated with an
increased occurrence of stroke (OR: 0.74; 95% CI: 0.58–0.95), renal
impairment (OR: 0.79; 95% CI: 0.71–0.89) and mediastinitis (OR:
0.44; 95% CI: 0.31–0.62). There was a signiﬁcantly lower volume of
chest tube drainage and transfusion in the OPCAB group but a
signiﬁcantly lower number of distal anastomosis.
Meta-analyses are important tools in the generation of scientiﬁc
evidence. However, they have several limitations. In the current
meta-analysis, 22 among 51 (43%) studies included <100 patients
[3]. Many of these randomized studies with limited population size
had non-clinical end-points and ill-deﬁned clinical outcomes,
included much selected patients (reﬂected in a signiﬁcantly higher
mean ejection fraction in patients undergoing OPCAB), did not
include risk-stratiﬁcation and provided no information on surgical
experience and important technical aspects, likely associated with
results. As an example, lack of data regarding aorta manipulation
prevents demonstration of larger OPCAB with no-touch aorta
impact on stroke reduction [4].
Interestingly, meta-analyses can reach opposite conclusions,
depending on inclusion criteria, quality of included studies,
selected end-points, duration of follow-up and methodological
issues. In a Cochrane review, Møller et al. [5] analysed 86 RCTs
encompassing 10 716 patients and reported that OPCAB resulted
in an increased all-cause mortality compared with ONCAB (3.7 vs
3.1%; P = 0.04) and no signiﬁcant difference in MI, stroke, renal in-
sufﬁciency or coronary reintervention but signiﬁcantly fewer distal
anastomosis performed in the OPCAB group (P = 0.001). On the
other hand, Aﬁlalo et al. [6] analysed 59 RCTs, encompassing 8961
patients and reported a signiﬁcant 30% reduction in the occur-
rence of postoperative stroke with OPCAB (risk ratio: 0.70; 95% CI:
0.49–0.99) with no signiﬁcant difference in mortality or MI.
Indeed, short of individual patient data collection, meta-
analyses are only as good as the included studies and the most
reﬁned statistical techniques cannot account for large heterogen-
eity and eliminate all possible sources of bias. A major problem
with RCTs, in surgery, is that ﬁndings can be hampered by differ-
ential expertise bias. In particular, a volume–outcome relationship
in OPCAB surgery has been demonstrated, with hospitals and sur-
geons in the highest percent OPCAB volume quartile displaying
adjusted mortality and morbidity rates signiﬁcantly lower when
compared with ONCAB, whereas results in the lowest quartile of
experience were similar [7]. Expertise-based randomized trials,
where surgeons perform only the procedure in which they have
expertise, have been proposed as a potential solution to enhance
the validity of surgical RCTs.
Critical appraisal of all forms of scientiﬁc evidence, including
meta-analysis, is at the core of recommendations for patient man-
agement. The present meta-analysis conﬁrms previous data
showing that OPCAB reduces selected short-term adverse events
and stroke with comparable mortality, MI and MACCE rates, but
with increased mid-term graft failure and need for repeat revascu-
larization. Increased saphenous graft occlusion after off-pump
surgery has also been reported in a recent meta-analysis, without
affecting internal thoracic artery patency [8]. The continued
debate over the best method for myocardial revascularization will
now focus on the trade-off between reduced early morbidity
including stroke versus potentially reduced graft patency and its
impact on late survival and quality of life. To conclude, the recent
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2014 ESC/EACTS guidelines on myocardial revascularization state
that (i) OPCAB should be considered for sub-groups of high-risk
patients in high-volume off-pump centres (level of evidence B)
and (ii) OPCAB and/or no-touch on-pump techniques on the
ascending aorta are recommended in patients with signiﬁcant ath-
erosclerotic disease of the ascending aorta in order to prevent
perioperative stroke (level of evidence B) [9].
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